Severe JA significantly impairs joint function and increases the risk of misdiagnosis as rheumatoid arthritis [4]. Serum levels of matrix metalloproteinase (MMP)-3 are elevated, while MMP-12 levels are reduced in patients with SLE. The gene discussed is MMP3; the disease is systemic lupus erythematosus.